John E. J. Rasko AO (born 1961[citation needed]) is an Australian clinical hematologist, pathologist and scientist whose research focuses on gene and stem cell therapy, experimental haematology and molecular biology. He directs the Department of Cell and Molecular Therapies at Royal Prince Alfred Hospital,[1] heads the Gene and Stem Cell Therapy Program at the Centenary Institute, Sydney,[2] and is Professor of Medicine, Sydney Medical School, the University of Sydney.[3] He is a science communicator, often interviewed on Australian radio and television, and is a regular contributor to Breakfast, Radio National, ABC.[4] Rasko delivered the ABC's 2018 Boyer Lectures. Entitled Life Re-engineered, they examined the history and impact of gene and cell therapies.[5]
John E. J. Rasko | |
|---|---|
 | |
| Nationality | Australian |
| Scientific career | |
| Fields | Stem-cell therapy, gene therapy, molecular biology, hematology |
| Institutions | Royal Prince Alfred Hospital, Centenary Institute, University of Sydney |
Rasko is Chair of the Gene Technology Technical Advisory Committee (GTTAC), Office of the Gene Technology Regulator (2008–),[6] and Chaired the Advisory Committee on Biologicals, Therapeutic Goods Administration (2012–15).[7] Contributions to scientific organisations include co-founder (2000) and past-President (2003–05) of the Australasian Gene and Cell Therapy Society (AGCTS); Vice President (2008–12), and President (2018–20), International Society for Cellular Therapy (ISCT), and founder (2009) of ISCT-Australia.[3][8]
He is a founding board member of the Cure the Future Foundation.[9] He is the Patron of Science for the FSHD Global Research Foundation, committed to the treatment and cure of facioscapulohumeral muscular dystrophy.[10] In 2009, he was instrumental in establishing the first Faculty Committee of the Faculty of Science, Royal College of Pathologists of Australasia,[3] and was a founding Fellow of the Australian Academy of Health and Medical Sciences.[8] He is the recipient of national and international awards in recognition of his medical research,[11] including appointment as an Officer of the Order of Australia.[12]
His 2021 book, Flesh Made New: The Unnatural History and Broken Promise of Stem Cells, co-authored by Carl Power, was longlisted for that year's Walkley Book Award.[13]
References
edit- ^ "Cell and Molecular Therapies". Sydney Local Health District. Archived from the original on 12 March 2018. Retrieved 23 February 2018.
- ^ "Professor John Rasko AO". Centenary Institute. Archived from the original on 12 March 2018. Retrieved 23 February 2018.
- ^ a b c "Professor John Rasko". Sydney Medical School, The University of Sydney. Archived from the original on 19 June 2017. Retrieved 23 February 2018.
- ^ "Media". Cure the Future. Archived from the original on 12 March 2018. Retrieved 23 February 2018.
- ^ "Boyer Lectures". ABC. Archived from the original on 9 January 2019. Retrieved 21 November 2018.
- ^ "GTTAC Members, 2017-2020" (PDF). Gene Technology Technical Advisory Committee (GTTAC). Archived (PDF) from the original on 12 March 2018. Retrieved 23 February 2018.
- ^ "Advisory Committee on Biologicals". Therapeutic Goods Administration. Archived from the original on 20 January 2013. Retrieved 23 February 2018.
- ^ a b "Prof. John Rasko AO". Cure the Future. Archived from the original on 12 March 2018. Retrieved 23 February 2018.
- ^ "Who We Are". Cure the Future. Archived from the original on 14 September 2009. Retrieved 23 February 2018.
- ^ "Patrons". FSHD Global Research Foundation. Archived from the original on 12 March 2018. Retrieved 23 February 2018.
- ^ "Professor John Rasko AO". Cure Cancer Australia. Archived from the original on 12 March 2018. Retrieved 23 February 2018.
- ^ "RASKO, John Edward". Australian Honours Search Facility, Department of the Prime Minister and Cabinet, Australian Government. Archived from the original on 12 March 2018. Retrieved 23 February 2018.
- ^ "2021 Walkley Book Award longlist announced". The Walkley Foundation. 24 November 2021. Retrieved 25 November 2021.